Urate Transporters: An Evolving Field

被引:37
作者
Anzai, Naohiko [2 ]
Endou, Hitoshi [1 ]
机构
[1] Kyorin Univ, Dept Pharmacol & Toxicol, Sch Med, Mitaka, Tokyo 1818611, Japan
[2] Dokkyo Med Univ, Dept Pharmacol & Toxicol, Sch Med, Shimotsuga, Tochigi, Japan
基金
日本学术振兴会;
关键词
Hypouricemia; hyperuricemia; gout; genome-wide association study; diuretics; URIC-ACID CONCENTRATIONS; GENOME-WIDE ASSOCIATION; PHOSPHATE TRANSPORTER; EFFLUX TRANSPORTER; PROXIMAL TUBULE; APICAL MEMBRANE; RENAL HYPOURICEMIA; ANION EXCHANGER; HUMAN KIDNEY; SERUM URATE;
D O I
10.1016/j.semnephrol.2011.08.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Urate (uric acid) is the end product of purine metabolism in human beings owing to the genetic loss of hepatic urate oxidase (uricase). Despite its potential advantage as an antioxidant, sustained hyperuricemia is associated with gout, renal diseases, hypertension, and cardiovascular diseases. Because the kidney plays a dominant role in maintaining serum urate levels through its excretion, it is important to understand the molecular mechanism of renal urate handling. Although molecular identification of the urate/anion exchanger URAT1 (SLC22A12) in 2002 paved the way for successive identification of several urate transport related proteins, the entire picture of effective renal urate handling in human beings has not yet been clarified. Recently, several genome-wide association studies have revealed close associations between serum urate levels and single nucleotide polymorphisms in at least 10 genetic loci including eight transporter-related genes. These findings led us to consider the roles of urate transporters in extrarenal tissues such as the intestine. In this review, we discuss various aspects of transmembrane transport of urate in the human body. Semin Nephrol 31:400-409 (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:400 / 409
页数:10
相关论文
共 60 条
[1]   The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus [J].
Anzai, N ;
Miyazaki, H ;
Noshiro, R ;
Khamdang, S ;
Chairoungdua, A ;
Shin, HJ ;
Enomoto, A ;
Sakamoto, S ;
Hirata, T ;
Tomita, K ;
Kanai, Y ;
Endou, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (44) :45942-45950
[2]   Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans [J].
Anzai, Naohiko ;
Ichida, Kimiyoshi ;
Jutabha, Promsuk ;
Kimura, Toru ;
Babu, Ellappan ;
Jin, Chun Ji ;
Srivastava, Sunena ;
Kitamura, Kenichiro ;
Hisatome, Ichiro ;
Endou, Hitoshi ;
Sakurai, Hiroyuki .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (40) :26834-26838
[3]   New insights into renal transport of urate [J].
Anzai, Naohiko ;
Kanai, Yoshikatsu ;
Endou, Hitoshi .
CURRENT OPINION IN RHEUMATOLOGY, 2007, 19 (02) :151-157
[4]   Organic anion transporter family: Current knowledge [J].
Anzai, Naohiko ;
Kanai, Yoshikatsu ;
Endou, Hitoshi .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 (05) :411-426
[5]   Renal urate handling: clinical relevance of recent advances. [J].
Anzai N. ;
Enomoto A. ;
Endou H. .
Current Rheumatology Reports, 2005, 7 (3) :227-234
[6]   Urate Transport: Regulators of Serum Urate Levels in Humans [J].
Anzai, Naohiko ;
Jutabha, Promsuk ;
Kimura, Toru ;
Fukutomi, Toshiyuki .
CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (02) :123-131
[7]   Renal Solute Transporters and Their Relevance to Serum Urate Disorder [J].
Anzai, Naohiko ;
Jutabha, Promsuk ;
Endou, Hitoshi .
CURRENT HYPERTENSION REVIEWS, 2010, 6 (03) :148-154
[8]  
Anzai N, 2010, J PHARMACOL SCI, V112, p202P
[9]   Drug discovery for hyperuricemia [J].
Anzai, Naohiko ;
Endou, Hitoshi .
EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (09) :1251-1261
[10]   Identification and characterization of human glucose transporter-like protein-9 (GLUT9) - Alternative splicing alters trafficking [J].
Augustin, R ;
Carayannopoulos, MO ;
Dowd, LO ;
Phay, JE ;
Moley, JF ;
Moley, KH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (16) :16229-16236